CRISPR-Cas–associated SCCmec Variants in Methicillin-resistant Staphylococcus aureus Evade Rapid Diagnostic Detection - Takeaways - MDSpire

CRISPR-Cas–associated SCCmec Variants in Methicillin-resistant Staphylococcus aureus Evade Rapid Diagnostic Detection

  • By

  • Magdalena Podkowik

  • Alice Tillman

  • Courtney Takats

  • Heloise Carion

  • Gregory Putzel

  • Julian McWilliams

  • Benjamin See

  • Guiqing Wang

  • Sigridh Munoz-Gomez

  • Caitlin Otto

  • Karl Drlica

  • Luciano Marraffini

  • Alejandro Pironti

  • Sarah Hochman

  • Christopher Kerantzas

  • Bo Shopsin

  • November 19, 2025

  • 0 min

Share

  • 1

    Variants of SCCmec associated with CRISPR-Cas can evade detection by rapid diagnostic assays for MRSA, leading to false-negative results.

  • 2

    A study identified 64 SCCmec variants from 45 patients, with 11 of 40 variants evading detection by BCID2 or Xpert assays.

  • 3

    Misdiagnosis was primarily linked to clonal complex 5, a hospital-associated lineage of MRSA.

  • 4

    The presence of CRISPR-Cas systems within SCCmec elements may compromise the accuracy of molecular MRSA detection.

  • 5

    Genomic surveillance is essential to monitor emerging diagnostic-escape variants of MRSA as they evolve in healthcare settings.

Original Source(s)

CRISPR-Cas–associated SCCmec Variants in Methicillin-resistant Staphylococcus aureus Evade Rapid Diagnostic Detection

  • by Magdalena Podkowik, Alice Tillman, Courtney Takats, Heloise Carion, Gregory Putzel, Julian McWilliams, Benjamin See, Guiqing Wang, Sigridh Munoz-Gomez, Caitlin Otto, Karl Drlica, Luciano Marraffini, Alejandro Pironti, Sarah Hochman, Christopher Kerantzas, Bo Shopsin

  • November 19, 2025

Related Content

Antibiotic Guideline Gaps Raise SSI Risk

Nonadherence to IDSA/SIS/SHEA perioperative antibiotic prophylaxis guidelines associated with significantly higher surgical site infection rates, finds nationwide analysis.

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Translational development and first-in-human compassionate infusion of NK-92 cells expressing a CD5-based chimeric antigen receptor (SRCD5CAR-NK-92) in a patient with multidrug-resistant fusariosis